Researchers at University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat diabetes and obesity, may help reduce liver scarring in patients with advanced fatty liver disease, including those with early-stage cirrhosis
Karen Mann, MD, Nooms Medical Director , for her insights
Evernorth Health Services recientemente lanz Evernorth EnGuide SM Pharmacy, una nueva farmacia centrada exclusivamente en la entrega a domicilio de GLP-1 para satisfacer la creciente demanda de estos medicamentos fundamentales
She understands how to balance hormones throughout the body and she is not a doctor that prescribes a one size fits all treatment plan
Lets explore how you can potentially minimize injection-site discomfort with GLP-1s
Nobody is born comfortable with needles